Is Pharming Group Nv Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: PHAR) stock is to Strong Buy PHAR stock.
Out of 3 analysts, 1 (33.33%) are recommending PHAR as a Strong Buy, 2 (66.67%) are recommending PHAR as a Buy, 0 (0%) are recommending PHAR as a Hold, 0 (0%) are recommending PHAR as a Sell, and 0 (0%) are recommending PHAR as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year PHAR price target, the average PHAR price target is $38.33, with the highest PHAR stock price forecast at $41.00 and the lowest PHAR stock price forecast at $37.00.
On average, Wall Street analysts predict that Pharming Group Nv's share price could reach $38.33 by Apr 10, 2027. The average Pharming Group Nv stock price prediction forecasts a potential upside of 115.35% from the current PHAR share price of $17.80.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.